Patents by Inventor Thomas Rades

Thomas Rades has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240000945
    Abstract: The present invention relates to co-amorphous form of a substance and a protein. The present invention also relates to pharmaceutical, cosmetic or veterinary compositions comprising the co-amorphous form as well as to methods for preparing and using the co-amorphous form.
    Type: Application
    Filed: February 8, 2023
    Publication date: January 4, 2024
    Inventors: Jaya Mishra, Adam Bohr, Thilo Berg, Korbinian Löbmann, Thomas Rades, Holger Grohganz, Jorrit Water
  • Publication number: 20240000708
    Abstract: The present invention relates to a drug delivery platform. In particular, it relates to a foil-based drug delivery platform for delivery to the intestine.
    Type: Application
    Filed: March 31, 2021
    Publication date: January 4, 2024
    Inventors: Anja Boisen, Lasse Hølund Eklund Thamdrup, Jacob Rune Jørgensen, Thomas Rades, Anette Müllertz, Mahdi Ghavami, Khorshid Kam Guyan
  • Patent number: 11484501
    Abstract: Particles are disclosed. Methods of making and using the particles are also disclosed.
    Type: Grant
    Filed: June 6, 2019
    Date of Patent: November 1, 2022
    Assignee: Grace GmbH
    Inventors: Hans Hermann Hoefer, Frederick Hendrik Monsuur, Thomas Pauly, Yogesh Choudhari, Korbinian Lobmann, Thomas Rades
  • Patent number: 11478424
    Abstract: Particles are disclosed. Methods of making and using the particles are also disclosed.
    Type: Grant
    Filed: September 30, 2016
    Date of Patent: October 25, 2022
    Assignee: Grace GmbH
    Inventors: Hans Hermann Hoefer, Frederik Hendrik Monsuur, Thomas Pauly, Yogesh Choudhari, Korbinian Lobmann, Thomas Rades
  • Publication number: 20200146989
    Abstract: The present invention relates to co-amorphous formulation of a substance and a dipeptide. The present invention also relates to pharmaceutical, cosmetic or veterinary compositions comprising the co-amorphous formulation as well as to methods for preparing and using the co-amorphous formulation.
    Type: Application
    Filed: December 22, 2017
    Publication date: May 14, 2020
    Inventors: Korbinian Löbmann, Thomas Rades, Holger Grohganz, Wenqi Wu, Jan Schnitzkewitz, Astrid Knuhtsen, Daniel Sejer Pedersen
  • Publication number: 20190350855
    Abstract: Particles are disclosed. Methods of making and using the particles are also disclosed.
    Type: Application
    Filed: June 6, 2019
    Publication date: November 21, 2019
    Inventors: Hans Hermann Hoefer, Frederick Hendrik Monsuur, Thomas Pauly, Yogesh Choudhari, Korbinian Lobmann, Thomas Rades
  • Publication number: 20190307886
    Abstract: The present invention relates to co-amorphous form of a substance and a protein. The present invention also relates to pharmaceutical, cosmetic or veterinary compositions comprising the co-amorphous form as well as to methods for preparing and using the co-amorphous form.
    Type: Application
    Filed: December 22, 2017
    Publication date: October 10, 2019
    Inventors: Jaya Mishra, Adam Bohr, Thilo Berg, Korbinian Löbmann, Thomas Rades, Holger Grohganz, Jorrit Water
  • Publication number: 20190151231
    Abstract: The present invention relates to non-aqueous topical compositions comprising a halogenated salicylanilide and the use of such compositions in the topical treatment or prevention of diseases and infections, particularly conditions caused by Gram-positive bacteria, for example the topical treatment or prevention of skin infections such as acne, atopic dermatitis and impetigo. Also disclosed are methods for preparing the gel composition.
    Type: Application
    Filed: March 15, 2017
    Publication date: May 23, 2019
    Applicants: Union Therapeutics A/S, KØBENHAVNS UNIVERSITET (UNIVERSITY OF COPENHAGEN)
    Inventors: Morten Otto Alexander SOMMER, Ping LI, Camilla Hasling FRANDSEN, Hanne Mørck NIELSEN, Petra Alexandra PRIEMEL, Thomas RADES
  • Publication number: 20180289621
    Abstract: Particles are disclosed. Methods of making and using the particles are also disclosed.
    Type: Application
    Filed: September 30, 2016
    Publication date: October 11, 2018
    Applicant: Grace GmbH
    Inventors: Hans Hermann Hoefer, Frederik Hendrik Monsuur, Thomas Pauly, Yogesh Choudhari, Korbinian Lobmann, Thomas Rades
  • Patent number: 9201052
    Abstract: A method of performing dissolution analysis on a tablet, the method comprising: irradiating a tablet with radiation having at least one frequency in the range from 40 GHz to 100 THz; detecting radiation which has been transmitted through or reflected by the tablet; determining a parameter from the detected radiation indicative of the density of a coating layer of the tablet; and determining information about the dissolution characteristics of the tablet from said parameter.
    Type: Grant
    Filed: January 29, 2008
    Date of Patent: December 1, 2015
    Assignee: TeraView Limited
    Inventors: Louise Ho, Yaochun Shen, Phillip F. Taday, Thomas Rades
  • Publication number: 20110275706
    Abstract: A pharmaceutical composition comprises at least one inhibitor of lipases, preferably an inhibitor of gastrointestinal and pancreatic lipases, such as orlistat, at least one surfactant, and at least one dispersant.
    Type: Application
    Filed: July 19, 2011
    Publication date: November 10, 2011
    Inventors: Passchier Christiaan de Smidt, Paul Hadvary, Hans Lengsfeld, Thomas Rades, Hans Steffen, Joseph Tardio
  • Patent number: 8012494
    Abstract: A pharmaceutical composition comprises at least one inhibitor of lipases, preferably an inhibitor of gastrointestinal and pancreatic lipases, such as orlistat, at least one surfactant, and at least one dispersant.
    Type: Grant
    Filed: March 5, 2004
    Date of Patent: September 6, 2011
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Passchier Christiaan de Smidt, Paul Hadvary, Hans Lengsfeld, Thomas Rades, Hans Steffen, Joseph Tardio
  • Publication number: 20100148070
    Abstract: A method of performing dissolution analysis on a tablet, the method comprising: irradiating a tablet with radiation having at least one frequency in the range from 40 GHz to 100 THz; detecting radiation which has been transmitted through or reflected by the tablet; determining a parameter from the detected radiation indicative of the density of a coating layer of the tablet; and determining information about the dissolution characteristics of the tablet from said parameter.
    Type: Application
    Filed: January 29, 2008
    Publication date: June 17, 2010
    Inventors: Louise Ho, Yaochun Shen, Phillip F. Taday, Thomas Rades
  • Publication number: 20040175420
    Abstract: A pharmaceutical composition comprises at least one inhibitor of lipases, preferably an inhibitor of gastrointestinal and pancreatic lipases, such as orlistat, at least one surfactant, and at least one dispersant.
    Type: Application
    Filed: March 5, 2004
    Publication date: September 9, 2004
    Inventors: Passchier Christiaan de Smidt, Paul Hadvary, Hans Lengsfeld, Thomas Rades, Hans Steffen, Joseph Tardio
  • Publication number: 20030181512
    Abstract: A pharmaceutical composition comprises at least one inhibitor of lipases, preferably an inhibitor of gastrointestinal and pancreatic lipases, such as orlistat, at least one surfactant, and at least one dispersant.
    Type: Application
    Filed: April 21, 2003
    Publication date: September 25, 2003
    Inventors: Passchier Christian de Smidt, Paul Hadvary, Hans Lengsfeld, Thomas Rades, Hans Steffen, Joseph Tardio
  • Patent number: 6534539
    Abstract: The present invention relates to compositions containing lipase inhibitors, e.g. orlistat, and the use of such compositions for treating, reducing or preventing functional dyspepsiaafter ingestion of meals, especially of fat containing or fat rich meals.
    Type: Grant
    Filed: August 6, 2001
    Date of Patent: March 18, 2003
    Assignee: Hoffman-La Roche Inc.
    Inventors: Christine Feinle, Michael Fried, Hans Lengsfeld, Thomas Rades
  • Publication number: 20020040049
    Abstract: The present invention relates to compositions containing lipase inhibitors, e.g. orlistat, and the use of such compositions for treating, reducing or preventing functional dyspepsiaafter ingestion of meals, especially of fat containing or fat rich meals.
    Type: Application
    Filed: August 6, 2001
    Publication date: April 4, 2002
    Inventors: Christine Feinle, Michael Fried, Hans Lengsfeld, Thomas Rades
  • Patent number: 6352717
    Abstract: The present invention provides a process for encapsulating a shear sensitive fill mass which contains a pharmaceutical active agent or nutrient, characterized in that said fill mass is heated and subsequently cooled, prior to the encapsulation. The invention also provides capsules comprising shear sensitive fill material obtained by the said process which have a high and constant dissolution rate.
    Type: Grant
    Filed: November 16, 1999
    Date of Patent: March 5, 2002
    Assignee: Hoffman-La Roche Inc.
    Inventors: Rainer Alex, Jürgen Gerhards, Ingeborg Kraemer-Pittrof, Richard Oeschger, Thomas Rades
  • Publication number: 20020006417
    Abstract: The present invention provides a process for encapsulating a shear sensitive fill mass which contains a pharmaceutical active agent or nutrient, characterised in that said fill mass is heated and subsequently cooled, prior to the encapsulation. The invention also provides capsules comprising shear sensitive fill material obtained by the said process which have a high and constant dissolution rate.
    Type: Application
    Filed: November 16, 1999
    Publication date: January 17, 2002
    Applicant: HOFFMANN-LA ROCHE INC.
    Inventors: RAINER ALEX, JURGEN GERHARDS, INGEBORG KRAEMER-PITTROF, RICHARD OESCHGER, THOMAS RADES